Earnings Call Summary | National Health Investors Inc(NHI.US) Q1 2025 Earnings Conference
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Maintains Target Price $86
National Health Investors Inc To Go Ex-Dividend On June 30th, 2025 With 0.9 USD Dividend Per Share
Strong Financial Performance and Strategic Initiatives Drive Buy Rating for National Health Investors
National Health Investors Q1 Normalized FFO, Revenue Rise; 2025 FFO Guidance Boosted
Express News | National Health Investors Raises FY2025 FFO Guidance From $4.59-$4.66 to $4.64-$4.70 Vs $4.65 Est
National Health Investors Q1 FFO $1.15 Beats $1.13 Estimate, Sales $89.30M Beat $84.76M Estimate
National Health Investors Inc | 8-K: NHI Announces First Quarter 2025 Results
National Health Investors Inc | 10-Q: Q1 2025 Earnings Report
Leading Proxy Advisory Firm Egan-Jones Recommends Stockholders Vote "FOR" All National Health Investors' Director Nominees
Earnings Scheduled For May 5, 2025
Exploring National Health Investors's Earnings Expectations
Omega Healthcare Extends Gains as Health Care REITs Sit Pretty Amid Market Uncertainty
NHI Mails Letter to Stockholders Highlighting Superior Shareholder Returns and Refreshed Board
NHI Announces First Quarter 2025 Earnings Release and Conference Call Dates
BofA Securities Initiates National Health Investors Inc(NHI.US) With Buy Rating, Announces Target Price $83
National Health Investors Price Target Lowered to $83 From $91 at BofA
If You Invested $10K In National Health Investors Stock 10 Years Ago, How Much Would You Have Now?
National Health Investors Activist Shareholder Nominates Alternate Board Slate
Land & Buildings Sends Letter to National Health Investors Stockholders and Files Definitive Proxy Materials Detailing Urgent Need for Boardroom Change